Cargando…
Serum thyroglobulin is associated with orbitopathy in Graves’ disease
PURPOSE: Serum thyroglobulin levels are often elevated in Graves’ disease (GD) and in most cases decrease during treatment. Its relation to Graves’ orbitopathy (GO) has not been clarified. Previously, a risk of GO has been linked to smoking, TSH receptor stimulation, high TSH-receptor antibodies (TR...
Autores principales: | Khamisi, S., Lundqvist, M., Emadi, P., Almby, K., Ljunggren, Ö., Karlsson, F. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357771/ https://www.ncbi.nlm.nih.gov/pubmed/33515213 http://dx.doi.org/10.1007/s40618-021-01505-8 |
Ejemplares similares
-
Comparison Between Thyroid Stimulating Immunoglobulin and
TSH-Receptor Antibodies in the Management of Graves’
Orbitopathy
por: Khamisi, Selwan, et al.
Publicado: (2023) -
Vitamin D and bone metabolism in Graves’ disease: a prospective study
por: Khamisi, S., et al.
Publicado: (2022) -
Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy
por: Lanzolla, G., et al.
Publicado: (2022) -
Graves' Orbitopathy
por: Hiromatsu, Yuji, et al.
Publicado: (2015) -
The Role of the Microbiota in Graves’ Disease and Graves’ Orbitopathy
por: Hou, Jueyu, et al.
Publicado: (2021)